Jerel Davis
QuietNamed in filings at Versant Venture CapitalOn the current fund
- Board seats filed
- 13
- Named on a board
all filings on record
Named in filings at Versant Venture CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Firefly Bio | Biotech & pharma | December 2023 | MPM BioVentures, Versant Vantage |
| Santa Ana Bio | Biotech & pharma | May 2021 | Versant Vantage |
| Graphite Bio | Biotech & pharma | March 2021 | Versant Vantage |
| RayzeBio | Biotech & pharma | August 2020 | Sofinnova Venture Partners, Versant Vantage |
| Tentarix Biotherapeutics | Biotech & pharma | July 2020 | Versant Vantage |
| Ventus Therapeutics U.S. | Biotech & pharma | November 2019 | Versant Vantage |
| Northern Mosaic | Biotech & pharma | June 2019 | Versant Vantage |
| Chinook Therapeutics U.S. | Biotech & pharma | February 2019 | Versant Vantage |
| Turnstone Biologics | Biotech & pharma | January 2019 | Versant Vantage |
| Travus Therapeutics | Not yet classified | June 2016 | Versant Vantage |
| Inception IBD | Biotech & pharma | December 2015 | Versant Vantage |
| ChanRx | Biotech & pharma | November 2011 | Versant Vantage |
| Mistral Therapeutics | Not yet classified | May 2011 | Versant Vantage |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Jerel Davis on the board, based on 11 filed seats with a verified or cited source.
2 more filed seats not yet classified, left out of the shares above.